Veriheal

DECEMBER 15, 2021

This is good news for cannabis consumers since a team of Canadian investigators recently revealed that insomniacs reported improvements in their sleep patterns after cannabis consumption. The team concluded that the observed improvement in insomnia symptoms demonstrates the cannabis plant’s suitability as a treatment option.

Sleep 98

Sleep Cannabinoids Therapy Treatment 98

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Forward-Looking Statements.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

CannaMD

MARCH 3, 2021

Law enforcement, policy makers, and public citizens have long debated how recreational marijuana legalization influences crime and public safety. Data tells us that more arrests for marijuana trafficking and possession occur after marijuana legalization in neighboring states, concentrated at the bordering counties.

Legalization 119

Legalization Marijuana Data Safety 119

The Cannigma

FEBRUARY 2, 2021

However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. In 2008, he published psychedelic safety guidelines.

Research and Development 98

Research and Development Therapy Data Treatment 98

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

The Cannigma

DECEMBER 20, 2021

Some of these have been identified as possible targets for the treatment of inflammatory skin conditions. The development of novel cannabis consumption methods, including those that avoid burning and smoke related chemicals, will decrease harmful effects to the skin and enhance the positive effects of the cannabis compounds.

Terpenes 133

Terpenes Cannabinoids Topical Research and Development 133

Veriheal

AUGUST 22, 2022

Based on the details of a June 21 press release, the trials—which are taking place in Johannesburg—are the first ethically approved studies exploring the suitability and safety of using cannabis as a substitute for opioid pain relievers. . S tudy subjects must be willing and ready to substitute opioids with cannabis. “We ” Conclusion

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

APRIL 1, 2022

The highest representative of Spanish pharmacists has proposed carrying out a pilot test in pharmacies to assess the use of cannabis for therapeutic purposes that will serve to collect data on the efficacy and safety of the use of cannabis-derived products.

Medicine 52

Medicine Data Safety Conditions 52

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

FEBRUARY 3, 2021

The gaining acceptance of cannabis in a legal sense allows researchers to study and perform testing on cannabis in order to get a better understanding of its mechanisms, safety, and efficacy. The study published in the Annals of Internal Medicine found that there is an increasing number of cannabis consumption by adults over the age of 55. .

Consumption 52

Consumption Safety THC Cannabis 52

Cannabis Law Report

SEPTEMBER 29, 2021

With patient safety at the center of its mission, TCI was created to educate healthcare professionals on the risks and benefits of medical cannabis, now legal in the state of New York and beyond. About The Cannabinoid Institute ??

Cannabinoids 52

Cannabinoids Education Patients Safety 52

Veriheal

OCTOBER 29, 2020

On the brighter side, Science Magazine has indicated that the funding for cannabis as an effective form of treatment and therapy is rising, however not as much as the funding for its adverse impacts are. The data for this graphic was provided by Jim Hudson at Hellth.com. . Why Focus Research on the Negatives of Cannabis?

Pharmaceutical 98

Pharmaceutical Therapy Cannabinoids Chronic Pain 98

The Cannigma

AUGUST 24, 2021

Best app for optimizing cannabis consumption – Jointly. Encouraging purposeful cannabis consumption is the stated goal of Jointly, a smart phone app devoted to helping cannabis fans and patients find the most reliable, safest, and effective cannabis products for them, so they can achieve their wellness goals. Learn More.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Cannabis Law Report

JUNE 7, 2019

. “Cannabis is clearly addictive and harmful, and there is no scientific evidence of the safety and efficacy of raw cannabis use,” the statement said. It concluded that “cannabis consumption is associated with irreversible brain damage, brain shrinkage, and serious mental or psychiatric illnesses” [link].

Pharmaceutical 40

Pharmaceutical Cannabinoids Safety Data 40

The Blunt Truth

AUGUST 13, 2019

Currently, the FDA treats CBD products aimed at human or animal consumption as drugs and therefore they cannot be distributed without prior approval or a rulemaking exception (more on this below). The FDA is collecting data to fill these gaps. The public hearing attracted over 100 speakers and 2000 participants.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

SEPTEMBER 23, 2021

The major concerns noted were adverse events following consumption (many from inadvertent intoxication), marketing to and use by minors, and the potential presence of harmful by-products and unsafe manufacturing practices. It focuses on the recent increases in adverse health events from delta-8 THC consumption now being tracked and monitored.

THC 52

THC Concentrates Pets DEA 52

MMJ Recs

FEBRUARY 23, 2024

The state’s dedication to patient well-being is reflected in its evolving regulations, ensuring safe and legal access to medical cannabis while promoting public health and safety. From the popularity of specific strains to evolving consumer preferences and consumption methods, the market analysis provides a comprehensive understanding.

Marijuana 52

Marijuana Dispensary Supply Chain Research and Development 52

Cannabis Law Report

JANUARY 23, 2022

At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments. More than 25,000 hematopoietic stem cell transplantations (HSCTs) are performed each year for the treatment of lymphoma, leukemia, immune-de?ciency Many variables impact the outcomes of GVHD. Implications.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

CannaMD

APRIL 28, 2021

Whereas some might believe steps taken by governments and organizations to screen and/or prevent cannabis use are supported by empirical evidence, such commentary is often based on speculation, vested interests, and pseudo-science rather than on objective interpretation of all available scientific data. Find Out if You Qualify. Get Started.

Marijuana 137

Marijuana Data Legalization Consumption 137

Veriheal

AUGUST 12, 2021

The authors added that in spite of the growing availability and diversity of alternative cannabinoid products like artisanal CBD—as opposed to pharmaceutical CBD—existing studies assessing their efficacy and/or safety are extremely rare. The majority of patients (74%) were Caucasian and more than half (55%) identified as female.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

The Cannigma

JULY 3, 2023

Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future. They found that it could be used in sessions to promote trust and safety, helping patients to open up and process traumatic experiences.

Research and Development 46

Research and Development Environment THC Microdosing 46

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 25, 2019

She added, “Here, we are faced with the challenge of balancing public safety concerns like robberies, which the use of body cameras are intended to deter, with individual privacy.”. Social Consumption Pilot Program. We depend on a good relationship with law enforcement. The next regulatory revision process is expected to occur in 2020.

Marijuana 40

Marijuana Safety Programs Retail 40

CannaMD

DECEMBER 9, 2020

Consumption of edibles should proceed slowly and in small quantities at a time with sufficient time between doses. The AHA position paper then moves on to address a range of known, potential, and suggested safety concerns associated with cannabis use. ACUTE EFFECTS OF MARIJUANA. CARDIAC AND VASCULAR EFFECTS. for men, 1.3% IMPURITIES.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

MAY 19, 2022

FDA states it has serious safety concerns with delta-8 THC. FDA considers delta-8 THC to pose serious health and safety risks. Food products for human or animal consumption that contain CBD or delta-8 THC are considered adulterated under the FFDCA. CBD oil is an effective natural treatment for OCD.”. “If Moving Forward.

THC 52

THC CBD Food Pets 52

Veriheal

MAY 16, 2022

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. and Torsten Falk, Ph.D.,

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Canna Law Blog

NOVEMBER 26, 2019

The Hemp Rules (WAC 16-306-100) establish a hemp food certification program where hemp producers can voluntarily certify hemp grown for human consumption. The WSDA will provide certification if a producer tests for the following: Nonapproved pesticide or herbicide use.

Hemp 89

Hemp Food Compliance Compliance 89

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. Ability to provide appropriate research data. Health and safety standards for lab employees.

Law 40

Law Marijuana Education Safety 40

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 60

Marijuana Therapy Data THC 60

Cannabis Law Report

JULY 20, 2019

In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Ability to meet the overall health needs of qualified patients and safety of the public. Ability to provide appropriate research data. By: Kristin Jordan , Senior Counsel.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. No data is available regarding prescriptions written in respect of secondary care. The Regulations define a CBPM as a preparation or product that. (a) Novel Foods Regulation.

Environment 45

Environment Food Seed-To-Sale Medicine 45

CannaMD

APRIL 15, 2020

To learn more about medical marijuana treatment center (MMTC) delivery services, please see: Florida Dispensaries: COVID-19 Policies. ” As the NORML memo notes, seventeen states still prohibit the legal use of cannabis for medical purposes and 39 states prohibit the consumption of the substance by adults. Find Out if You Qualify.

Policy 55

Policy Patients Dispensary Banking 55

Cannabis Law Report

JULY 23, 2019

It is important that they conduct medical research into the safety and effectiveness of cannabis products through adequate and well-controlled clinical trials. Some states require mandatory warning statements in advertisements for medical cannabis. required to provide other warnings that may be needed by the commission.

Law 40

Law Clinical Trials CBD Edibles 40

Cannabis Law Report

APRIL 14, 2022

Part 180, Subparts D and E; that the pesticide be labeled as expressly for use on crops intended for human consumption; and that the pesticide’s active ingredients must be allowed by EPA for use on tobacco. Next Steps. As the cannabis industry matures, more regulation is sure to follow and, with that, additional risks and opportunities.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

OCTOBER 15, 2021

But consumers who buy products in this unregulated CBD market have no access to data showing the actual CBD and THC content of these products and have no way to determine whether these products are free of adulterants. . S ee FD&C Act Section 301(ll) and Section 201(ff)(3)(B). Department of Public Health Jurisdiction and Oversight .

Food 52

Food Cannabinoids Hemp Legalization 52